Lv32
270 积分 2023-12-29 加入
Global, Regional, and National Burden of Breast Cancer Among Females, 1990–2023, With Forecasts to 2050: A Systematic Analysis for the Global Burden of Disease Study 2023
17天前
已完结
Subcutaneous atezolizumab for the treatment of non-small cell lung cancer
19天前
已关闭
Subcutaneous Immunotherapy in Cancer: Where We Are Now, What It Changes, and What to Watch Next
24天前
已关闭
Epidemiology and Economic Burden of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma in the United States
1个月前
已完结
De-escalated surgery following neoadjuvant chemoimmunotherapy for locally advanced oral squamous cell carcinoma: A retrospective cohort study
1个月前
已完结
Neoadjuvant Chemoimmunotherapy for Resectable Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-analysis
1个月前
已完结
Neoadjuvant Immunotherapy and Chemoimmunotherapy Regimens in Head and Neck Cancer
1个月前
已完结
Hormone Receptor and HER2 Testing in Breast Cancer
1个月前
已关闭
Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challenges
1个月前
已完结
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores
1个月前
已完结
皖公网安备34019202002308
